ArticleOncology letters2014

Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients.

Kouji Izumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.